About 2 results found for searched term "Belantamab Mafodotin" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40542 | Belantamab Mafodotin | ADC Linker |
| GSK2857916 | ||
| Belantamab Mafodotin is a first-in-class antibody-drug concatenation (ADC) against B cell maturation antigen (BCMA). It contains antibodies targeting BCMA as well as the microtubule inhibitor monomethylauristatin F (MMAF) and may be used in studies related to multiple myeloma (MM). | ||
| M24899 | Belantamab | TNF Receptor |
| GSK2857914 | ||
| Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
